Diabetes Care (2013) 36:294551
Tissues were immediately deep frozen in liquid nitrogen, and stored at 80 C until used
These symptoms occurred largely during the dose-escalation period, were transient and mild/moderate in severity, and led to drug discontinuation in up to 7% of participants in each active therapy group
Tirzepatide can: Currently, tirzepatide is only available as a once-a-week injectable medication
We tested our hypothesis using data from the PASADENA study 3 , by comparing the change from baseline on MDS-UPDRS Part III using a Mixed-Effects Model for Repeated Measures (MMRM) with a TTE approach (i.e., time to meaningful motor progression)
My colleague Rhonda Lintner, MPH, BS, shares practical insights on how hospitals and compounding pharmacies can stay always readynot scrambling when inspectors arrive